Neurologic manifestations of elderly patients with cancer
- 39 Downloads
The incidence of cancer is an age-related phenomenon; therefore, the interest on clinical manifestations, diagnostic approach and treatment strategies for older patients diagnosed with cancer has increased lately. Neurologic symptoms are one of the main reasons for consultation and a common cause of decreased quality of life among cancer patients.
To identify the neurologic manifestations of patients ≥ 65 years of age diagnosed with cancer and compare them to those presented by a younger population.
Cross-sectional study of cancer patients referred to neuro-oncologic consultation at a Cancer Center. Sociodemographic, health and oncologic characteristics were obtained through clinical interviews. Clinical symptoms and final diagnoses were also recorded. Bivariate logistic regression analyses were carried out.
More than 17,000 neuro-oncologic consultations in 3015 patients were given, 27% (n = 811) of them were ≥ 65 years of age. Most frequent primary neoplasms in elderly patients were: breast cancer, hematologic neoplasms, gynecological, urologic, skin and head and neck cancers. Elderly patients had an increased risk of having the following diagnoses: abnormal movements, stroke, peripheral vertigo, dementia, degenerative spine disorder, and delirium.
Elderly patients are considered a vulnerable population. The present study found that the main neoplasms associated with neurological manifestations are similar to the reported previously. We described the main symptoms that led to a neuro-oncological assessment. Moreover, we enlisted the final diagnoses made on elderly patients and compared them with others reports. To the best of our knowledge, this study provides valuable information, since there is scarce evidence in the literature about this topic.
Identifying the frequency and correlation of neurologic manifestations in older cancer patients will allow for the implementation of timely multidisciplinary care in an attempt to improve these patients’ health-related quality of life.
KeywordsElderly Cancer Neuro-oncology Neoplasms Quality of life
BC-D: study concepts, study design, data acquisition, quality control of data and algorithms. NAL-M, GR-S: data analysis and interpretation, statistical analysis, manuscript preparation. JAÁ-F, APN-R: manuscript editing and manuscript review.
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Compliance with ethical standards
Conflict of interest
The authors declare no conflicts of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Institutional ethics and scientific committee approved this research.
Human and animal rights
This article does not contain any studies with animals performed by any of the authors.
For this type of study formal consent is not required.
- 15.Wildiers H, Tryfonidis K, Dal Lago L et al. (2018) Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group. Lancet Oncol 19:323–36. https://doi.org/10.1016/S1470-2045(18)30083-4 CrossRefPubMedGoogle Scholar
- 16.Aparicio T, Lavau-Denes S, Phelip JM et al (2015) Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02). Ann Oncol 27:121–127 https://doi.org/10.1093/annonc/mdv491 CrossRefPubMedGoogle Scholar
- 17.Corre R, Greillier L, Le Caër H et al (2016) Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non–small-cell lung cancer: the phase III randomized ESOGIA-GFPC-GECP 08-02 study. J Clin Oncol 34:1476–1483 https://doi.org/10.1200/JCO.2015.63.5839 CrossRefPubMedGoogle Scholar
- 20.Gachet J, Girre V, Brain E et al (2010) Outcome of older patients with breast cancer with brain metastases. J Clin Oncol 28:e11501–e11501. https://doi.org/10.1200/jco.2010.28.15_suppl.e11501 CrossRefGoogle Scholar
- 36.Flannery TW, Suntharalingam M, Regine WF et al (2008) Long-term survival in patients with synchronous, solitary brain metastasis from non–small-cell lung cancer treated with radiosurgery. Int J Radiat Oncol Biol Phys 72:19–23. https://doi.org/10.1016/j.ijrobp.2007.12.031 CrossRefPubMedGoogle Scholar